But it can also create a new problem: eating too little of the foods your body still needs
MASLD is a heterogeneous disease influenced by genetic, metabolic, and environmental factors
After scrapping a Biden-era plan to cover obesity drugs in early 2025, the Trump administration reversed course: it struck deals with Novo Nordisk and Eli Lilly in November 2025 to cut GLP-1 prices, and a voluntary Medicare demonstration begins July 1, 2026 that lets participating drug plans cover GLP-1s for weight loss with a $50 monthly copay
Diabetes-related complications : Long-term health problems caused by uncontrolled diabetes, including nerve damage, kidney disease, and heart issues
PlexusDx bypasses insurance gatekeeping entirely, letting patients with prediabetes, metabolic syndrome, or simple weight-loss goals begin treatment within days rather than months